Proteonomix, Inc. is a biotechnology company engaged in the discovery and development of stem cell therapeutic and cosmeceutical products. We are developing pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Our discoveries involve non embryonic stem cell treatments.

We have developed sufficient technology for patent applications including a medium and a scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a unique cord blood banking cryopreservation bag and cosmetic products utilizing a secreted matrix derived from stem cells. We have developed some of our intellectual property utilizing our management and advisory team in conjunction with third party universities and research centers. We have concentrated on our cosmeceutical treatments based on our licensed technology which we believe will be our lead revenue product in the market. We have completed the development of our cosmeceutical products and we anticipate sales to begin in the first quarter of 2010.

For further information or documentation please contact:

Investor relations:
info@proteonomix.com